ABCL fundamentals
AbCellera Biologics Inc. earnings per share and revenue
ABCL earnings per share for the last quarter are -0.12 USD whereas the estimation was -0.13 USD which accounts for 10.00% surprise. Company revenue for the same period amounts to 5.10 M USD despite the estimated figure of 7.58 M USD. Estimated earnings per share for the next quarter are -0.14 USD, and revenue is expected to reach 7.05 M USD. Also watch annual changes over time to get a bigger picture of ABCL earnings per share and revenue dynamics.
Next report date
≈
Report periodQ1 2025
EPS estimate−0.14USD
Revenue estimate7.05 MUSD
EPS
Forecast
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
−0.18
−0.14
−0.09
−0.04
0.00
Reported
Estimate
Currency: USD
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
−0.14
−0.11
−0.10
−0.16
−0.14
−0.13
−0.17
−0.12
—
—
—
—
Estimate
−0.13
−0.13
−0.12
−0.11
−0.13
−0.12
−0.12
−0.13
−0.14
−0.14
−0.15
−0.15
Surprise
−8.89%
+18.09%
+17.43%
−39.28%
−11.58%
−8.33%
−36.61%
+10.00%
—
—
—
—
Revenue
Forecast
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
0.00
3.50 M
7.00 M
10.50 M
14.00 M
Reported
Estimate
Currency: USD
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
12.19 M
10.06 M
6.60 M
9.20 M
9.95 M
7.32 M
6.51 M
5.10 M
—
—
—
—
Estimate
12.11 M
12.38 M
11.48 M
8.89 M
10.73 M
10.12 M
7.68 M
7.58 M
7.05 M
6.68 M
6.84 M
6.61 M
Surprise
+0.69%
−18.75%
−42.50%
+3.45%
−7.23%
−27.62%
−15.26%
−32.70%
—
—
—
—